» Authors » Nutnicha Sirikaew

Nutnicha Sirikaew

Explore the profile of Nutnicha Sirikaew including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 80
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Thongkumkoon P, Sangphukieo A, Tongjai S, Noisagul P, Sangkhathat S, Laochareonsuk W, et al.
Sci Rep . 2024 Sep; 14(1):21092. PMID: 39256458
No abstract available.
2.
Thongkumkoon P, Sangphukieo A, Tongjai S, Noisagul P, Sangkhathat S, Laochareonsuk W, et al.
Sci Rep . 2024 May; 14(1):11056. PMID: 38744935
Osteosarcoma is the most common malignant bone cancer in pediatric patients. Patients who respond poorly to chemotherapy experience worse clinical outcomes with a high mortality rate. The major challenge is...
3.
Dukaew N, Thongkumkoon P, Sirikaew N, Dissook S, Sakuludomkan W, Tongjai S, et al.
Pharmaceutics . 2023 Jun; 15(6). PMID: 37376182
Mycophenolic acid (MPA) and trimethoprim-sulfamethoxazole (TMP-SMX) are commonly prescribed together in certain groups of patients, including solid organ transplant recipients. However, little is known about the pharmacokinetic drug-drug interactions (DDIs)...
4.
Tangyuenyong S, Kongdang P, Sirikaew N, Ongchai S
Vet World . 2022 Oct; 15(7):1869-1879. PMID: 36185520
Background And Aim: Osteoarthritis (OA) is recognized as a degenerative joint disease that leads to chronic pain and low quality of life in animals. Captive elephants, the largest land mammals...
5.
Sirikaew N, Pruksakorn D, Chaiyawat P, Chutipongtanate S
Int J Mol Sci . 2022 Sep; 23(17). PMID: 36077137
Due to a lack of novel therapies and biomarkers, the clinical outcomes of osteosarcoma patients have not significantly improved for decades. The advancement of mass spectrometry (MS), peptide quantification, and...
6.
Chaiyawat P, Phanphaisarn A, Sirikaew N, Klangjorhor J, Thepbundit V, Teeyakasem P, et al.
Sci Rep . 2021 May; 11(1):10887. PMID: 34035425
Osteosarcoma is one of the most aggressive bone tumors in children and adolescents. Development of effective therapeutic options is still lacking due to the complexity of the genomic background. In...
7.
Chaiyawat P, Sirikaew N, Budprom P, Klangjorhor J, Phanphaisarn A, Teeyakasem P, et al.
J Bone Oncol . 2020 Oct; 25:100321. PMID: 33072501
Background: Abnormality in the DNA methylation process is one of the hallmarks of cancer. Emerging evidence strongly supports the idea that defects in DNA methyl transferases (DNMTs) are involved in...
8.
Sirikaew N, Chomdej S, Tangyuenyong S, Tangjitjaroen W, Somgird C, Thitaram C, et al.
BMC Vet Res . 2019 Nov; 15(1):419. PMID: 31752879
Background: Osteoarthritis (OA), the most common form of arthritic disease, results from destruction of joint cartilage and underlying bone. It affects animals, including Asian elephants (Elephas maximus) in captivity, leading...
9.
Klangjorhor J, Chaiyawat P, Teeyakasem P, Sirikaew N, Phanphaisarn A, Settakorn J, et al.
Int J Cancer . 2019 Oct; 146(12):3397-3409. PMID: 31609477
Our previous review of proteomics data showed that in osteosarcoma, some overexpressed proteins were targets of FDA-approved immunosuppressive and anti-arrhythmic drugs, including mycophenolate mofetil (MMF), ribavirin, leflunomide, azathioprine and digoxin....
10.
Kuensaen C, Chomdej S, Kongdang P, Sirikaew N, Jaitham R, Thonghoi S, et al.
PLoS One . 2019 Jul; 14(7):e0218736. PMID: 31260471
LL-37 is the only human cathelicidin-family host defense peptide and has been reported to interact with invading pathogens causing inflammation at various body sites. Recent studies showed high levels of...